RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 24 filers reported holding RECRO PHARMA INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,343,000 | -54.6% | 333,200 | -43.5% | 0.39% | -48.2% |
| Q1 2017 | $5,157,000 | +6.1% | 590,000 | -2.2% | 0.75% | +14.4% |
| Q4 2016 | $4,860,000 | -17.8% | 603,000 | -9.9% | 0.66% | +0.5% |
| Q3 2016 | $5,916,000 | -4.4% | 669,239 | -14.0% | 0.65% | -25.7% |
| Q2 2016 | $6,187,000 | +32.9% | 778,288 | -0.2% | 0.88% | +24.9% |
| Q1 2016 | $4,657,000 | -33.7% | 780,000 | 0.0% | 0.70% | -16.4% |
| Q4 2015 | $7,020,000 | -25.2% | 780,000 | 0.0% | 0.84% | -44.0% |
| Q3 2015 | $9,383,000 | -6.9% | 780,000 | 0.0% | 1.50% | +11.9% |
| Q2 2015 | $10,078,000 | +69.4% | 780,000 | +18.9% | 1.34% | +45.8% |
| Q1 2015 | $5,949,000 | +197.2% | 655,907 | -6.3% | 0.92% | +197.4% |
| Q4 2014 | $2,002,000 | -3.4% | 700,000 | 0.0% | 0.31% | -27.5% |
| Q3 2014 | $2,072,000 | -48.3% | 700,000 | +40.0% | 0.43% | -59.8% |
| Q2 2014 | $4,005,000 | +9.4% | 500,000 | 0.0% | 1.06% | +26.0% |
| Q1 2014 | $3,660,000 | – | 500,000 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samjo Capital LLC | 8,039,100 | $3,770,338 | 1.48% |
| First Light Asset Management, LLC | 19,676,396 | $9,228,230 | 0.88% |
| AWM Investment Company, Inc. | 10,266,144 | $4,814,822 | 0.71% |
| Caligan Partners LP | 1,689,768 | $794,191 | 0.36% |
| HighMark Wealth Management LLC | 484,985 | $227,458 | 0.19% |
| Nantahala Capital Management | 1,250,000 | $586,250 | 0.05% |
| Clear Harbor Asset Management, LLC | 938,847 | $440,319 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,249,229 | $1,992,888 | 0.03% |
| TITLEIST ASSET MANAGEMENT, LLC | 210,148 | $98,559 | 0.02% |
| ROYCE & ASSOCIATES LP | 3,285,082 | $1,540,703 | 0.02% |